Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
THYROX is a specialized Atlantic krill oil (*Euphausia superba*) dietary supplement developed and studied by the Poznan University of Physical Education. It is formulated to contain high concentrations of omega-3 fatty acids (specifically eicosapentaenoic acid and docosahexaenoic acid), phospholipids, and the antioxidant astaxanthin. The supplement is primarily investigated for its ability to protect red blood cell physiology and modulate iron metabolism markers in high-performance athletes, such as professional rowers. Its mechanism of action involves the inhibition of lipid peroxidation and ferroptosis, which helps maintain red blood cell membrane integrity against the oxidative stress induced by intense physical training.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on THYROX.